BACKGROUND AND AIMS: Sentinel lymph node biopsy (SLNB) has been widely accepted as a precise tool to stage melanoma. In thin T1 melanomas (<or=1 mm), the indication of SLNB is controversial since the risk of nodal metastasis is low. The aim of this study was to assess if SLNB detects occult nodal metastases among patients with thin melanomas. PATIENTS AND METHODS: SLNB was performed prospectively in 135 patients with invasive melanoma in any depth category, including 56 T1 melanomas. RESULTS: Nodal metastases were detected in 18% by SLNB, and there were three sentinel-positive thin melanomas, constituting 5% of the T1 cases. Histopathologically, there were no factors of the primary tumors that would have predicted these metastases. CONCLUSION: SLNB is a precise method to detect clinically silent nodal metastases in thin invasive melanoma. Certain histopathologic features of a thin primary lesion may correlate with the predictive probability of the sentinel node status. We were unable to identify these predictors, but the conclusions from this study are limited by the small sample size. Advanced melanoma is a lethal disease, and accurate staging is essential also in the T1 group. For stage III patients with occult nodal metastases, metastasectomy is a better option for cure than observation.
BACKGROUND AND AIMS: Sentinel lymph node biopsy (SLNB) has been widely accepted as a precise tool to stage melanoma. In thin T1 melanomas (<or=1 mm), the indication of SLNB is controversial since the risk of nodal metastasis is low. The aim of this study was to assess if SLNB detects occult nodal metastases among patients with thin melanomas. PATIENTS AND METHODS: SLNB was performed prospectively in 135 patients with invasive melanoma in any depth category, including 56 T1 melanomas. RESULTS: Nodal metastases were detected in 18% by SLNB, and there were three sentinel-positive thin melanomas, constituting 5% of the T1 cases. Histopathologically, there were no factors of the primary tumors that would have predicted these metastases. CONCLUSION: SLNB is a precise method to detect clinically silent nodal metastases in thin invasive melanoma. Certain histopathologic features of a thin primary lesion may correlate with the predictive probability of the sentinel node status. We were unable to identify these predictors, but the conclusions from this study are limited by the small sample size. Advanced melanoma is a lethal disease, and accurate staging is essential also in the T1 group. For stage III patients with occult nodal metastases, metastasectomy is a better option for cure than observation.
Authors: Vernon K Sondak; Jeremy M G Taylor; Michael S Sabel; Yue Wang; Lori Lowe; Amelia C Grover; Alfred E Chang; Alan M Yahanda; James Moon; Timothy M Johnson Journal: Ann Surg Oncol Date: 2004-03 Impact factor: 5.344
Authors: C L Nguyen; E F McClay; D J Cole; P H O'Brien; W E Gillanders; J S Metcalf; J C Maize; P L Baron Journal: Am J Surg Date: 2001-01 Impact factor: 2.565
Authors: R S Oliveira Filho; L M Ferreira; L J Biasi; M M S S Enokihara; G R Paiva; J Wagner Journal: Braz J Med Biol Res Date: 2003-03-07 Impact factor: 2.590
Authors: Karyn B Stitzenberg; Pamela A Groben; Stacey L Stern; Nancy E Thomas; Thomas A Hensing; Leah B Sansbury; David W Ollila Journal: Ann Surg Oncol Date: 2004-09-20 Impact factor: 5.344
Authors: Anne Brecht Francken; Helen M Shaw; John F Thompson; Seng-jaw Soong; Neil A Accortt; Manuela F Azzola; Richard A Scolyer; Gerald W Milton; William H McCarthy; Marjorie H Colman; Vincent J McGovern Journal: Ann Surg Oncol Date: 2004-03-15 Impact factor: 5.344
Authors: John L Zapas; H Christopher Coley; Sandra L Beam; Sally D Brown; Kathleen A Jablonski; E George Elias Journal: J Am Coll Surg Date: 2003-09 Impact factor: 6.113
Authors: Doreen M Agnese; Shahab F Abdessalam; William E Burak; Cynthia M Magro; Rodney V Pozderac; Michael J Walker Journal: Surgery Date: 2003-10 Impact factor: 3.982
Authors: Phyllis A Gimotty; DuPont Guerry; Michael E Ming; Rosalie Elenitsas; Xiaowei Xu; Brian Czerniecki; Francis Spitz; Lynn Schuchter; David Elder Journal: J Clin Oncol Date: 2004-08-09 Impact factor: 44.544
Authors: Melanie A Warycha; Jan Zakrzewski; Quanhong Ni; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Iman Osman Journal: Cancer Date: 2009-02-15 Impact factor: 6.860